Imperial Innovations Group plc is a venture capital and private equity firm specializing in all stages of development including incubation, seed, early stage, growth capital, development funding, and later stage investments. The firm typically invests in all sectors. It focuses on technology, all-things-saas (software-as-a-service), analytics, security, bioengineering, therapeutics, software, hardware, healthcare, medical devices, and diagnostics, energy, engineering, materials, clean tech, digital, environment, and bioscience companies founded by or based on technology and intellectual property from the University of Oxford, the University of Cambridge, Imperial College, and University College, London. It primarily invests in companies based in the United Kingdom. The firm typically invests between £0.02 million ($0.03 million) and £1 million ($1.71 million). It also invests between £1 million ($1.71 million) and £5 million ($8.55 million) and further between £5 million ($8.55 million) and above £25 million ($42.76 million) for stake building purposes. The firm prefers to lead or co-lead its investments. It also makes subsequent funding technology rounds working in partnership with founders, management, and co-investors. The firm seeks to take a board seat on its portfolio companies. It also provides technology transfer services and targets companies based on the intellectual property from Imperial College. Imperial Innovations Group plc was founded in 1986 and is based in London, the United Kingdom with an additional office in Cambridge, United Kingdom.
imperial innovations group p
(IVO:London Stock Exchange)
52 Princes Gate
London, SW7 2PG
Phone: 44 20 7581 4949
Fax: 44 20 7594 6584www.imperialinnovations.co.uk
|Health Discovery Corp||$0.02 USD||0.00|
|Miraculins Inc||C$0.25 CAD||+0.02|
|Myriad Genetics Inc||$36.65 USD||+0.45|
|Vermillion Inc||$1.74 USD||-0.11|
|View Industry Companies|
Sponsored Financial Commentaries
To contact IMPERIAL INNOVATIONS GROUP P, please visit www.imperialinnovations.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.